POMC, proopiomelanocortin, 5443

N. diseases: 873; N. variants: 39
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.330 Biomarker disease BEFREE The present study proposes α-MSH as a potential therapeutic agent to stimulate bone formation for osteoporosis and bone defect. 30496742 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.330 Biomarker disease CTD_human Cushing's disease in dogs and humans. 19153526 2009
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.330 GeneticVariation disease LHGDN Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women. 15864412 2005
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.330 GeneticVariation disease BEFREE Osteoporosis was subsequently discovered in one of our previously reported patients with ACTH insensitivity. 1655458 1991
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.330 Biomarker disease CTD_human Disturbed calcium and phosphate homeostasis during treatment with ACTH of infantile spasms. 3017235 1986
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.330 Biomarker disease CTD_human Renal and pancreatic calcification during treatment of infantile spasms with ACTH. 6143199 1984
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.330 Biomarker disease CTD_human ACTH therapy in infantile spasms: side effects. 6254450 1980
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.330 Biomarker disease CTD_human Cushing's syndrome secondary to ACTH-secreting Wilms' tumor. 4367732 1974